Gilead Sciences, Inc. (GILD)

Healthcare

$148.75

LAST CLOSE · SEP 30

Gilead Sciences, Inc. (GILD) is a Healthcare stock tracked by StreetAlpha. It last closed at $148.75 on Sep 30. GILD reports earnings on Thu, Oct 29, 2026. The average 12-month price target from 6 analysts is $148.50 (-0.2% from the last close), with a high of $175.00 and a low of $123.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (3 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in GILD, 100% of them bullish and 0% bearish. In the past 30 days there were 11 dark pool prints totaling $38.9M, the largest $15.0M.

FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily Cboe FLEX report for unusually large, long-dated positions.

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GILD is in one of them and how their past GILD trades turned out.

StreetAlpha hasn't covered GILD in an article yet. Here's the latest on the wider market.